Last Updated: November 13, 2026

Pai Holdings Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for PAI HOLDINGS PHARM

PAI HOLDINGS PHARM has thirty-four approved drugs.

Summary for Pai Holdings Pharm

US Patents:	0
Tradenames:	32
Ingredients:	27
NDAs:	34

Drugs and US Patents for Pai Holdings Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pai Holdings Pharm	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	088786-001	Sep 11, 1984		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Pai Holdings Pharm	LIDOCAINE HYDROCHLORIDE VISCOUS	lidocaine hydrochloride	SOLUTION;ORAL	218138-001	Feb 20, 2024	AT	RX	No	No		⤷ Start Trial				⤷ Start Trial
Pai Holdings Pharm	ZINACEF	cefuroxime sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	050558-002	Oct 19, 1983		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-003	Jul 19, 1985		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-004	Jul 19, 1985		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Pai Holdings Pharm

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,128,658	⤷ Start Trial
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,128,658	⤷ Start Trial
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,659	⤷ Start Trial
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,658	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.